Serum IL-17 and IL-23 levels can distinguish between severe and non-severe inflammatory bowel disease

被引：0
|
作者：
Lucaciu, L. [1 ,2 ]
Ilies, M. [3 ]
Iuga, C. [3 ,4 ]
Seicean, A. [1 ,2 ]
机构：
[1] Iuliu Hatieganu Univ Med & Pharm, Gastroenterol & Hepatol, Cluj Napoca, Romania
[2] Reg Inst Gastroenterol & Hepatol, Cluj Napoca, Romania
[3] Iuliu Hatieganu Univ Med & Pharm, Dept Pharmaceut Anal, Fac Pharm, Cluj Napoca, Romania
[4] MedFuture Res Ctr Adv Med, Dept Prote & Metabol, Cluj Napoca, Romania
来源：
JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P136
引用
收藏
页码：S163 / S163
页数：1
相关论文
共 50 条
  • [21] EXPRESSION LEVELS OF IL-17, IL-22 AND IL-23 RECEPTORS IN FOUR OSTEOBLAST MODELS AND THE EFFECTS OF IL-17, IL-22 AND IL-23 ON OSTEOBLASTS
    Zhang, J. -R.
    Dai, S. -M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 627 - 628
  • [22] How Can We Manipulate the IL-23/IL-17 Axis?
    Ling Zhao
    Daniela Ghetie
    Zhenyu Jiang
    Cong-Qiu Chu
    Current Treatment Options in Rheumatology, 2015, 1 (2) : 182 - 196
  • [23] Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis
    Mei, Yang
    Pan, Faming
    Gao, Jing
    Ge, Rui
    Duan, Zhenhua
    Zeng, Zhen
    Liao, Fangfang
    Xia, Guo
    Wang, Sheng
    Xu, Shengqian
    Xu, Jianhua
    Zhang, Li
    Ye, Dongqing
    CLINICAL RHEUMATOLOGY, 2011, 30 (02) : 269 - 273
  • [24] Modeling the Distinct Roles for IL-23 and IL-17 in Inflammatory Bowel Disease Using Mdr1a-/- Mice
    Maxwell, Joe
    Brown, William
    Zhang, Yu
    Rottman, James B.
    Budelsky, Alison
    Towne, Jennifer
    GASTROENTEROLOGY, 2013, 144 (05) : S806 - S806
  • [25] Novel Pharmacological Approaches for Inflammatory Bowel Disease: Targeting Key Intracellular Pathways and the IL-23/IL-17 Axis
    Fitzpatrick, Leo R.
    INTERNATIONAL JOURNAL OF INFLAMMATION, 2012, 2012
  • [26] Lactic Acid Bacteria with Concomitant IL-17, IL-23 and TNFα- Binding Ability for the Treatment of Inflammatory Bowel Disease
    Kosler, Stasa
    Strukelj, Borut
    Berlec, Ales
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2017, 18 (04) : 318 - 326
  • [27] DISSOCIATION OF SERUM IL-23 AND IL-17 LEVELS IN PATIENTS WITH SPONDYLOARTHRITIS ACCORDING TO RADIOGRAPHIC STAGE
    Yeo, J.
    Lee, H. Y.
    Seo, M. R.
    Choi, H. J.
    Baek, H. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1227 - 1227
  • [28] Comparison of Serum IL-23 and IL-17 Levels in Patients with Systemic Sclerosis and Healthy Subjects
    Celal, Demir
    Ali, Sahin
    Orhan, Kucuksahin
    Murat, Turgay
    Nuran, Turkcapar
    Sukran, Erten
    Gulay, Kinikli
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2015, 6 (01) : 83 - 87
  • [29] Plasma levels of IL-17 and IL-23 in the patients with Multiple Sclerosis
    Yusefipour, Gholam Ali
    Sarvestani, Eskandar Kamali
    Jamebozorgi, Khosro
    Sharifian, Maryam
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (05) : 673 - 674
  • [30] A safety assessment of biological therapies targeting the IL-23/IL-17 axis in inflammatory bowel diseases
    Verstockt, Bram
    Deleenheer, Barbara
    Van Assche, Gert
    Vermeire, Severine
    Ferrante, Marc
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (07) : 809 - 821
12345